APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tuberculosis Drugs Market Analysis and Forecast 2026-2032

22 December 2025204 pages

Choose your research edition.

Industry ResearchTuberculosis Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Tuberculosis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis Drugs Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Tuberculosis Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tuberculosis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tuberculosis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tuberculosis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tuberculosis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tuberculosis Drugs include Abbott, Teva Pharmaceutical Industries Ltd, Sanofi, Johnson & Johnson, Novartis AG, Eli Lilly and Company, Pfizer Inc, AstraZeneca Plc and Viatris Inc. (Mylan N.V.), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tuberculosis Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tuberculosis Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Tuberculosis Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tuberculosis Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tuberculosis Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tuberculosis Drugs sales, projected growth trends, production technology, application and end-user industry.

Tuberculosis Drugs Segment by Company

Abbott

Teva Pharmaceutical Industries Ltd

Sanofi

Johnson & Johnson

Novartis AG

Eli Lilly and Company

Pfizer Inc

AstraZeneca Plc

Viatris Inc. (Mylan N.V.)

Sun Pharmaceutical Industries Ltd.

Otsuka Pharmaceutical

Macleods Pharmaceuticals Ltd.

Lupin Laboratories Ltd

FRESENIUS SE & Co. KGaA (Fresenius Kabi)

Cipla Ltd

Cadila Pharmaceuticals

ANI Pharmaceuticals, Inc

Alkem Laboratories Ltd

Tuberculosis Drugs Segment by Type

First Line Drugs Therapy

Combination Drugs Therapy

Second Line Drugs Therapy

Tuberculosis Drugs Segment by Application

Hospital

Private Clinic

Others

Tuberculosis Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tuberculosis Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tuberculosis Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tuberculosis Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. First Line Drugs Therapy Major Manufacturers Table 3. Combination Drugs Therapy Major Manufacturers Table 4. Second Line Drugs Therapy Major Manufacturers Table 5. Global Tuberculosis Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Private Clinic Major Manufacturers Table 8. Others Major Manufacturers Table 9. Tuberculosis Drugs Industry Trends Table 10. Tuberculosis Drugs Industry Drivers Table 11. Tuberculosis Drugs Industry Opportunities and Challenges Table 12. Tuberculosis Drugs Industry Restraints Table 13. Global Tuberculosis Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Tuberculosis Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Tuberculosis Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Tuberculosis Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Tuberculosis Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Tuberculosis Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Tuberculosis Drugs Sales by Region (2021-2026) & (k units) Table 20. Global Tuberculosis Drugs Sales by Region (2027-2032) & (k units) Table 21. Global Tuberculosis Drugs Sales Market Share by Region (2021-2026) Table 22. Global Tuberculosis Drugs Sales Market Share by Region (2027-2032) Table 23. Global Tuberculosis Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Tuberculosis Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Tuberculosis Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Tuberculosis Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Tuberculosis Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Tuberculosis Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Tuberculosis Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Tuberculosis Drugs Manufacturers, Product Type & Application Table 31. Global Tuberculosis Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Tuberculosis Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Tuberculosis Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Tuberculosis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Tuberculosis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Tuberculosis Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Tuberculosis Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Tuberculosis Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Tuberculosis Drugs Sales by Type (2021-2026) & (k units) Table 41. Global Tuberculosis Drugs Sales by Type (2027-2032) & (k units) Table 42. Global Tuberculosis Drugs Sales Market Share by Type (2021-2026) Table 43. Global Tuberculosis Drugs Sales Market Share by Type (2027-2032) Table 44. Global Tuberculosis Drugs Price by Type (2021-2026) & (US$/unit) Table 45. Global Tuberculosis Drugs Price by Type (2027-2032) & (US$/unit) Table 46. Global Tuberculosis Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Tuberculosis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Tuberculosis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Tuberculosis Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Tuberculosis Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Tuberculosis Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Tuberculosis Drugs Sales by Application (2021-2026) & (k units) Table 53. Global Tuberculosis Drugs Sales by Application (2027-2032) & (k units) Table 54. Global Tuberculosis Drugs Sales Market Share by Application (2021-2026) Table 55. Global Tuberculosis Drugs Sales Market Share by Application (2027-2032) Table 56. Global Tuberculosis Drugs Price by Application (2021-2026) & (US$/unit) Table 57. Global Tuberculosis Drugs Price by Application (2027-2032) & (US$/unit) Table 58. Abbott Company Information Table 59. Abbott Business Overview Table 60. Abbott Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Abbott Tuberculosis Drugs Product Portfolio Table 62. Abbott Recent Development Table 63. Teva Pharmaceutical Industries Ltd Company Information Table 64. Teva Pharmaceutical Industries Ltd Business Overview Table 65. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Portfolio Table 67. Teva Pharmaceutical Industries Ltd Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Sanofi Tuberculosis Drugs Product Portfolio Table 72. Sanofi Recent Development Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Johnson & Johnson Tuberculosis Drugs Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Novartis AG Company Information Table 79. Novartis AG Business Overview Table 80. Novartis AG Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Novartis AG Tuberculosis Drugs Product Portfolio Table 82. Novartis AG Recent Development Table 83. Eli Lilly and Company Company Information Table 84. Eli Lilly and Company Business Overview Table 85. Eli Lilly and Company Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Eli Lilly and Company Tuberculosis Drugs Product Portfolio Table 87. Eli Lilly and Company Recent Development Table 88. Pfizer Inc Company Information Table 89. Pfizer Inc Business Overview Table 90. Pfizer Inc Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Pfizer Inc Tuberculosis Drugs Product Portfolio Table 92. Pfizer Inc Recent Development Table 93. AstraZeneca Plc Company Information Table 94. AstraZeneca Plc Business Overview Table 95. AstraZeneca Plc Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. AstraZeneca Plc Tuberculosis Drugs Product Portfolio Table 97. AstraZeneca Plc Recent Development Table 98. Viatris Inc. (Mylan N.V.) Company Information Table 99. Viatris Inc. (Mylan N.V.) Business Overview Table 100. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Portfolio Table 102. Viatris Inc. (Mylan N.V.) Recent Development Table 103. Sun Pharmaceutical Industries Ltd. Company Information Table 104. Sun Pharmaceutical Industries Ltd. Business Overview Table 105. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Portfolio Table 107. Sun Pharmaceutical Industries Ltd. Recent Development Table 108. Otsuka Pharmaceutical Company Information Table 109. Otsuka Pharmaceutical Business Overview Table 110. Otsuka Pharmaceutical Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Otsuka Pharmaceutical Tuberculosis Drugs Product Portfolio Table 112. Otsuka Pharmaceutical Recent Development Table 113. Macleods Pharmaceuticals Ltd. Company Information Table 114. Macleods Pharmaceuticals Ltd. Business Overview Table 115. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Portfolio Table 117. Macleods Pharmaceuticals Ltd. Recent Development Table 118. Lupin Laboratories Ltd Company Information Table 119. Lupin Laboratories Ltd Business Overview Table 120. Lupin Laboratories Ltd Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Lupin Laboratories Ltd Tuberculosis Drugs Product Portfolio Table 122. Lupin Laboratories Ltd Recent Development Table 123. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Company Information Table 124. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Business Overview Table 125. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Portfolio Table 127. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Recent Development Table 128. Cipla Ltd Company Information Table 129. Cipla Ltd Business Overview Table 130. Cipla Ltd Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Cipla Ltd Tuberculosis Drugs Product Portfolio Table 132. Cipla Ltd Recent Development Table 133. Cadila Pharmaceuticals Company Information Table 134. Cadila Pharmaceuticals Business Overview Table 135. Cadila Pharmaceuticals Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Cadila Pharmaceuticals Tuberculosis Drugs Product Portfolio Table 137. Cadila Pharmaceuticals Recent Development Table 138. ANI Pharmaceuticals, Inc Company Information Table 139. ANI Pharmaceuticals, Inc Business Overview Table 140. ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Portfolio Table 142. ANI Pharmaceuticals, Inc Recent Development Table 143. Alkem Laboratories Ltd Company Information Table 144. Alkem Laboratories Ltd Business Overview Table 145. Alkem Laboratories Ltd Tuberculosis Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Alkem Laboratories Ltd Tuberculosis Drugs Product Portfolio Table 147. Alkem Laboratories Ltd Recent Development Table 148. North America Tuberculosis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 149. North America Tuberculosis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 150. North America Tuberculosis Drugs Sales by Type (2021-2026) & (k units) Table 151. North America Tuberculosis Drugs Sales by Type (2027-2032) & (k units) Table 152. North America Tuberculosis Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 153. North America Tuberculosis Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 154. North America Tuberculosis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 155. North America Tuberculosis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 156. North America Tuberculosis Drugs Sales by Application (2021-2026) & (k units) Table 157. North America Tuberculosis Drugs Sales by Application (2027-2032) & (k units) Table 158. North America Tuberculosis Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 159. North America Tuberculosis Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 160. North America Tuberculosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. North America Tuberculosis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. North America Tuberculosis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. North America Tuberculosis Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 164. North America Tuberculosis Drugs Sales by Country (2021-2026) & (k units) Table 165. North America Tuberculosis Drugs Sales by Country (2027-2032) & (k units) Table 166. North America Tuberculosis Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 167. North America Tuberculosis Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 168. United States Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 169. Canada Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 170. Mexico Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 171. Europe Tuberculosis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 172. Europe Tuberculosis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 173. Europe Tuberculosis Drugs Sales by Type (2021-2026) & (k units) Table 174. Europe Tuberculosis Drugs Sales by Type (2027-2032) & (k units) Table 175. Europe Tuberculosis Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 176. Europe Tuberculosis Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 177. Europe Tuberculosis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 178. Europe Tuberculosis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 179. Europe Tuberculosis Drugs Sales by Application (2021-2026) & (k units) Table 180. Europe Tuberculosis Drugs Sales by Application (2027-2032) & (k units) Table 181. Europe Tuberculosis Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 182. Europe Tuberculosis Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 183. Europe Tuberculosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Europe Tuberculosis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Europe Tuberculosis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Europe Tuberculosis Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 187. Europe Tuberculosis Drugs Sales by Country (2021-2026) & (k units) Table 188. Europe Tuberculosis Drugs Sales by Country (2027-2032) & (k units) Table 189. Europe Tuberculosis Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 190. Europe Tuberculosis Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 191. Germany Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 192. France Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 193. U.K. Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 194. Italy Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 195. Russia Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 196. Spain Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 197. Netherlands Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 198. Switzerland Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 199. Sweden Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 200. Poland Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 201. China Tuberculosis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 202. China Tuberculosis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 203. China Tuberculosis Drugs Sales by Type (2021-2026) & (k units) Table 204. China Tuberculosis Drugs Sales by Type (2027-2032) & (k units) Table 205. China Tuberculosis Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 206. China Tuberculosis Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 207. China Tuberculosis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 208. China Tuberculosis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 209. China Tuberculosis Drugs Sales by Application (2021-2026) & (k units) Table 210. China Tuberculosis Drugs Sales by Application (2027-2032) & (k units) Table 211. China Tuberculosis Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 212. China Tuberculosis Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 213. Asia Tuberculosis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 214. Asia Tuberculosis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 215. Asia Tuberculosis Drugs Sales by Type (2021-2026) & (k units) Table 216. Asia Tuberculosis Drugs Sales by Type (2027-2032) & (k units) Table 217. Asia Tuberculosis Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 218. Asia Tuberculosis Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 219. Asia Tuberculosis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 220. Asia Tuberculosis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 221. Asia Tuberculosis Drugs Sales by Application (2021-2026) & (k units) Table 222. Asia Tuberculosis Drugs Sales by Application (2027-2032) & (k units) Table 223. Asia Tuberculosis Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 224. Asia Tuberculosis Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 225. Asia Tuberculosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. Asia Tuberculosis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. Asia Tuberculosis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. Asia Tuberculosis Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 229. Asia Tuberculosis Drugs Sales by Country (2021-2026) & (k units) Table 230. Asia Tuberculosis Drugs Sales by Country (2027-2032) & (k units) Table 231. Asia Tuberculosis Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 232. Asia Tuberculosis Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 233. Japan Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 234. South Korea Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 235. India Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 236. Australia Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 237. Taiwan Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 238. Southeast Asia Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 239. SAMEA Tuberculosis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 240. SAMEA Tuberculosis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 241. SAMEA Tuberculosis Drugs Sales by Type (2021-2026) & (k units) Table 242. SAMEA Tuberculosis Drugs Sales by Type (2027-2032) & (k units) Table 243. SAMEA Tuberculosis Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 244. SAMEA Tuberculosis Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 245. SAMEA Tuberculosis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 246. SAMEA Tuberculosis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 247. SAMEA Tuberculosis Drugs Sales by Application (2021-2026) & (k units) Table 248. SAMEA Tuberculosis Drugs Sales by Application (2027-2032) & (k units) Table 249. SAMEA Tuberculosis Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 250. SAMEA Tuberculosis Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 251. SAMEA Tuberculosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 252. SAMEA Tuberculosis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 253. SAMEA Tuberculosis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 254. SAMEA Tuberculosis Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 255. SAMEA Tuberculosis Drugs Sales by Country (2021-2026) & (k units) Table 256. SAMEA Tuberculosis Drugs Sales by Country (2027-2032) & (k units) Table 257. SAMEA Tuberculosis Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 258. SAMEA Tuberculosis Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 259. Brazil Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 260. Argentina Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 261. Chile Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 262. Colombia Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 263. Peru Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 264. Saudi Arabia Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 265. Israel Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 266. UAE Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 267. Turkey Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 268. Iran Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 269. Egypt Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Table 270. Key Raw Materials Table 271. Raw Materials Key Suppliers Table 272. Tuberculosis Drugs Distributors List Table 273. Tuberculosis Drugs Customers List Table 274. Research Programs/Design for This Report Table 275. Authors List of This Report Table 276. Secondary Sources Table 277. Primary Sources List of Figures Figure 1. Tuberculosis Drugs Image Figure 2. Global Tuberculosis Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. First Line Drugs Therapy Image Figure 5. Combination Drugs Therapy Image Figure 6. Second Line Drugs Therapy Image Figure 7. Global Tuberculosis Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Tuberculosis Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Private Clinic Image Figure 11. Others Image Figure 12. Global Tuberculosis Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Tuberculosis Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Tuberculosis Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Tuberculosis Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Tuberculosis Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Tuberculosis Drugs Sales (2021-2032) & (k units) Figure 18. Global Tuberculosis Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Tuberculosis Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Tuberculosis Drugs Sales YoY (2021-2032) & (k units) Figure 21. Europe Tuberculosis Drugs Sales YoY (2021-2032) & (k units) Figure 22. China Tuberculosis Drugs Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Tuberculosis Drugs Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Tuberculosis Drugs Sales YoY (2021-2032) & (k units) Figure 25. Global Tuberculosis Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Tuberculosis Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Tuberculosis Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Tuberculosis Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Tuberculosis Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Tuberculosis Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Tuberculosis Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Tuberculosis Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Tuberculosis Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Tuberculosis Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Tuberculosis Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Tuberculosis Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Tuberculosis Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Tuberculosis Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Tuberculosis Drugs Revenue Share by Type (2021-2032) Figure 41. North America Tuberculosis Drugs Sales Share by Type (2021-2032) Figure 42. North America Tuberculosis Drugs Revenue Share by Application (2021-2032) Figure 43. North America Tuberculosis Drugs Sales Share by Application (2021-2032) Figure 44. North America Tuberculosis Drugs Revenue Share by Country (2021-2032) Figure 45. North America Tuberculosis Drugs Sales Share by Country (2021-2032) Figure 46. Europe Tuberculosis Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Tuberculosis Drugs Sales Share by Type (2021-2032) Figure 48. Europe Tuberculosis Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Tuberculosis Drugs Sales Share by Application (2021-2032) Figure 50. Europe Tuberculosis Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Tuberculosis Drugs Sales Share by Country (2021-2032) Figure 52. China Tuberculosis Drugs Revenue Share by Type (2021-2032) Figure 53. China Tuberculosis Drugs Sales Share by Type (2021-2032) Figure 54. China Tuberculosis Drugs Revenue Share by Application (2021-2032) Figure 55. China Tuberculosis Drugs Sales Share by Application (2021-2032) Figure 56. Asia Tuberculosis Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Tuberculosis Drugs Sales Share by Type (2021-2032) Figure 58. Asia Tuberculosis Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Tuberculosis Drugs Sales Share by Application (2021-2032) Figure 60. Asia Tuberculosis Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Tuberculosis Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Tuberculosis Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Tuberculosis Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Tuberculosis Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Tuberculosis Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Tuberculosis Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Tuberculosis Drugs Sales Share by Country (2021-2032) Figure 68. Tuberculosis Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Tuberculosis Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • First Line Drugs Therapy
  • Combination Drugs Therapy
  • Second Line Drugs Therapy
Applications
  • Hospital
  • Private Clinic
  • Others
Companies covered
  • Abbott
  • Teva Pharmaceutical Industries Ltd
  • Sanofi
  • Johnson & Johnson
  • Novartis AG
  • Eli Lilly and Company
  • Pfizer Inc
  • AstraZeneca Plc
  • Viatris Inc. (Mylan N.V.)
  • Sun Pharmaceutical Industries Ltd.
  • Otsuka Pharmaceutical
  • Macleods Pharmaceuticals Ltd.
  • Lupin Laboratories Ltd
  • FRESENIUS SE & Co. KGaA (Fresenius Kabi)
  • Cipla Ltd
  • Cadila Pharmaceuticals
  • ANI Pharmaceuticals, Inc
  • Alkem Laboratories Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tuberculosis Drugs Market by Type
  3. 1.2.1 Global Tuberculosis Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 First Line Drugs Therapy
  5. 1.2.3 Combination Drugs Therapy
  6. 1.2.4 Second Line Drugs Therapy
  7. 1.3 Tuberculosis Drugs Market by Application
  8. 1.3.1 Global Tuberculosis Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Private Clinic
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Tuberculosis Drugs Market Dynamics
  1. 2.1 Tuberculosis Drugs Industry Trends
  2. 2.2 Tuberculosis Drugs Industry Drivers
  3. 2.3 Tuberculosis Drugs Industry Opportunities and Challenges
  4. 2.4 Tuberculosis Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tuberculosis Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tuberculosis Drugs Revenue by Region
  3. 3.2.1 Global Tuberculosis Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tuberculosis Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Tuberculosis Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Tuberculosis Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tuberculosis Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tuberculosis Drugs Sales by Region
  9. 3.4.1 Global Tuberculosis Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tuberculosis Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Tuberculosis Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Tuberculosis Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tuberculosis Drugs Revenue by Manufacturers
  2. 4.1.1 Global Tuberculosis Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tuberculosis Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tuberculosis Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tuberculosis Drugs Sales by Manufacturers
  6. 4.2.1 Global Tuberculosis Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tuberculosis Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tuberculosis Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tuberculosis Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tuberculosis Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tuberculosis Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tuberculosis Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Tuberculosis Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tuberculosis Drugs Market CR5 and HHI
  16. 4.8.2 2025 Tuberculosis Drugs Tier 1, Tier 2, and Tier 3
5 Tuberculosis Drugs Market by Type
  1. 5.1 Global Tuberculosis Drugs Revenue by Type
  2. 5.1.1 Global Tuberculosis Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tuberculosis Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tuberculosis Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tuberculosis Drugs Sales by Type
  6. 5.2.1 Global Tuberculosis Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tuberculosis Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Tuberculosis Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tuberculosis Drugs Price by Type
6 Tuberculosis Drugs Market by Application
  1. 6.1 Global Tuberculosis Drugs Revenue by Application
  2. 6.1.1 Global Tuberculosis Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tuberculosis Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tuberculosis Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tuberculosis Drugs Sales by Application
  6. 6.2.1 Global Tuberculosis Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tuberculosis Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Tuberculosis Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tuberculosis Drugs Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Tuberculosis Drugs Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Teva Pharmaceutical Industries Ltd
  8. 7.2.1 Teva Pharmaceutical Industries Ltd Company Information
  9. 7.2.2 Teva Pharmaceutical Industries Ltd Business Overview
  10. 7.2.3 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Portfolio
  12. 7.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Tuberculosis Drugs Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Johnson & Johnson
  20. 7.4.1 Johnson & Johnson Company Information
  21. 7.4.2 Johnson & Johnson Business Overview
  22. 7.4.3 Johnson & Johnson Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Johnson & Johnson Tuberculosis Drugs Product Portfolio
  24. 7.4.5 Johnson & Johnson Recent Developments
  25. 7.5 Novartis AG
  26. 7.5.1 Novartis AG Company Information
  27. 7.5.2 Novartis AG Business Overview
  28. 7.5.3 Novartis AG Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis AG Tuberculosis Drugs Product Portfolio
  30. 7.5.5 Novartis AG Recent Developments
  31. 7.6 Eli Lilly and Company
  32. 7.6.1 Eli Lilly and Company Company Information
  33. 7.6.2 Eli Lilly and Company Business Overview
  34. 7.6.3 Eli Lilly and Company Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eli Lilly and Company Tuberculosis Drugs Product Portfolio
  36. 7.6.5 Eli Lilly and Company Recent Developments
  37. 7.7 Pfizer Inc
  38. 7.7.1 Pfizer Inc Company Information
  39. 7.7.2 Pfizer Inc Business Overview
  40. 7.7.3 Pfizer Inc Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Inc Tuberculosis Drugs Product Portfolio
  42. 7.7.5 Pfizer Inc Recent Developments
  43. 7.8 AstraZeneca Plc
  44. 7.8.1 AstraZeneca Plc Company Information
  45. 7.8.2 AstraZeneca Plc Business Overview
  46. 7.8.3 AstraZeneca Plc Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 AstraZeneca Plc Tuberculosis Drugs Product Portfolio
  48. 7.8.5 AstraZeneca Plc Recent Developments
  49. 7.9 Viatris Inc. (Mylan N.V.)
  50. 7.9.1 Viatris Inc. (Mylan N.V.) Company Information
  51. 7.9.2 Viatris Inc. (Mylan N.V.) Business Overview
  52. 7.9.3 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Portfolio
  54. 7.9.5 Viatris Inc. (Mylan N.V.) Recent Developments
  55. 7.10 Sun Pharmaceutical Industries Ltd.
  56. 7.10.1 Sun Pharmaceutical Industries Ltd. Company Information
  57. 7.10.2 Sun Pharmaceutical Industries Ltd. Business Overview
  58. 7.10.3 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Portfolio
  60. 7.10.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  61. 7.11 Otsuka Pharmaceutical
  62. 7.11.1 Otsuka Pharmaceutical Company Information
  63. 7.11.2 Otsuka Pharmaceutical Business Overview
  64. 7.11.3 Otsuka Pharmaceutical Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Otsuka Pharmaceutical Tuberculosis Drugs Product Portfolio
  66. 7.11.5 Otsuka Pharmaceutical Recent Developments
  67. 7.12 Macleods Pharmaceuticals Ltd.
  68. 7.12.1 Macleods Pharmaceuticals Ltd. Company Information
  69. 7.12.2 Macleods Pharmaceuticals Ltd. Business Overview
  70. 7.12.3 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Portfolio
  72. 7.12.5 Macleods Pharmaceuticals Ltd. Recent Developments
  73. 7.13 Lupin Laboratories Ltd
  74. 7.13.1 Lupin Laboratories Ltd Company Information
  75. 7.13.2 Lupin Laboratories Ltd Business Overview
  76. 7.13.3 Lupin Laboratories Ltd Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Lupin Laboratories Ltd Tuberculosis Drugs Product Portfolio
  78. 7.13.5 Lupin Laboratories Ltd Recent Developments
  79. 7.14 FRESENIUS SE & Co. KGaA (Fresenius Kabi)
  80. 7.14.1 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Company Information
  81. 7.14.2 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Business Overview
  82. 7.14.3 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Portfolio
  84. 7.14.5 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Recent Developments
  85. 7.15 Cipla Ltd
  86. 7.15.1 Cipla Ltd Company Information
  87. 7.15.2 Cipla Ltd Business Overview
  88. 7.15.3 Cipla Ltd Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Cipla Ltd Tuberculosis Drugs Product Portfolio
  90. 7.15.5 Cipla Ltd Recent Developments
  91. 7.16 Cadila Pharmaceuticals
  92. 7.16.1 Cadila Pharmaceuticals Company Information
  93. 7.16.2 Cadila Pharmaceuticals Business Overview
  94. 7.16.3 Cadila Pharmaceuticals Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Cadila Pharmaceuticals Tuberculosis Drugs Product Portfolio
  96. 7.16.5 Cadila Pharmaceuticals Recent Developments
  97. 7.17 ANI Pharmaceuticals, Inc
  98. 7.17.1 ANI Pharmaceuticals, Inc Company Information
  99. 7.17.2 ANI Pharmaceuticals, Inc Business Overview
  100. 7.17.3 ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Portfolio
  102. 7.17.5 ANI Pharmaceuticals, Inc Recent Developments
  103. 7.18 Alkem Laboratories Ltd
  104. 7.18.1 Alkem Laboratories Ltd Company Information
  105. 7.18.2 Alkem Laboratories Ltd Business Overview
  106. 7.18.3 Alkem Laboratories Ltd Tuberculosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Alkem Laboratories Ltd Tuberculosis Drugs Product Portfolio
  108. 7.18.5 Alkem Laboratories Ltd Recent Developments
8 North America
  1. 8.1 North America Tuberculosis Drugs Market Size by Type
  2. 8.1.1 North America Tuberculosis Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Tuberculosis Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Tuberculosis Drugs Price by Type (2021-2032)
  5. 8.2 North America Tuberculosis Drugs Market Size by Application
  6. 8.2.1 North America Tuberculosis Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Tuberculosis Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Tuberculosis Drugs Price by Application (2021-2032)
  9. 8.3 North America Tuberculosis Drugs Market Size by Country
  10. 8.3.1 North America Tuberculosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tuberculosis Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tuberculosis Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Tuberculosis Drugs Market Size by Type
  2. 9.1.1 Europe Tuberculosis Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tuberculosis Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Tuberculosis Drugs Price by Type (2021-2032)
  5. 9.2 Europe Tuberculosis Drugs Market Size by Application
  6. 9.2.1 Europe Tuberculosis Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tuberculosis Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Tuberculosis Drugs Price by Application (2021-2032)
  9. 9.3 Europe Tuberculosis Drugs Market Size by Country
  10. 9.3.1 Europe Tuberculosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tuberculosis Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tuberculosis Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Tuberculosis Drugs Market Size by Type
  2. 10.1.1 China Tuberculosis Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Tuberculosis Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Tuberculosis Drugs Price by Type (2021-2032)
  5. 10.2 China Tuberculosis Drugs Market Size by Application
  6. 10.2.1 China Tuberculosis Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Tuberculosis Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Tuberculosis Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tuberculosis Drugs Market Size by Type
  2. 11.1.1 Asia Tuberculosis Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tuberculosis Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Tuberculosis Drugs Price by Type (2021-2032)
  5. 11.2 Asia Tuberculosis Drugs Market Size by Application
  6. 11.2.1 Asia Tuberculosis Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tuberculosis Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Tuberculosis Drugs Price by Application (2021-2032)
  9. 11.3 Asia Tuberculosis Drugs Market Size by Country
  10. 11.3.1 Asia Tuberculosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tuberculosis Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tuberculosis Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tuberculosis Drugs Market Size by Type
  2. 12.1.1 SAMEA Tuberculosis Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tuberculosis Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tuberculosis Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Tuberculosis Drugs Market Size by Application
  6. 12.2.1 SAMEA Tuberculosis Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tuberculosis Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tuberculosis Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Tuberculosis Drugs Market Size by Country
  10. 12.3.1 SAMEA Tuberculosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tuberculosis Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tuberculosis Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tuberculosis Drugs Value Chain Analysis
  2. 13.1.1 Tuberculosis Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tuberculosis Drugs Production Mode & Process
  6. 13.2 Tuberculosis Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tuberculosis Drugs Distributors
  9. 13.2.3 Tuberculosis Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst